
Allstate Corp (ALL) stock reached an all-time high of $213.18, reflecting robust investor confidence and an 18.9% gain over the past 12 months. This milestone follows a strong Q2 2025 performance, where the insurer significantly beat expectations with EPS of $5.94 and revenue of $16.6 billion. Consequently, analysts have revised earnings estimates upward and raised price targets, with firms like KBW and BMO Capital setting new targets of $246 and $235 respectively, indicating a positive outlook and suggesting the stock may still be undervalued despite its record valuation.
Allstate Corp. (ALL) has demonstrated significant operational and market strength, with its stock reaching an all-time high of $213.18. This performance is underpinned by a robust second quarter for 2025, where the company substantially surpassed analyst expectations, reporting earnings per share of $5.94 against a forecast of $3.32 and revenue of $16.6 billion versus a $15.22 billion projection. The positive results have triggered a wave of upward revisions from analysts, with Keefe, Bruyette & Woods raising its price target to $246 and BMO Capital to $235, citing the earnings beat and a lower expense ratio. Fundamentally, the company appears solid, trading at an attractive P/E ratio of 9.7x and carrying an InvestingPro "GREAT" financial health score, supported by a 33-year history of uninterrupted dividend payments. However, some tempering factors exist; BMO noted weaker near-term buybacks, and Wells Fargo's more conservative $202 price target reflects concerns over market declines in key states like New York and New Jersey.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.80
Ticker Sentiment